G&J Marketing and Sales, LLC – Trademark Portfolio
Entity Type: 16
G&J Marketing and Sales, LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include OMEGACLEAN and OMEGACLEAN PPE PERSONAL PROTECTION EXPERTS. The owner is based in Palm Harbor, FL.
292 Alternate 19, North
Palm Harbor, FL 34683
Showing of trademarks Trademarks
Trademark Classifications
G&J Marketing and Sales, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does G&J Marketing and Sales, LLC have?
G&J Marketing and Sales, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.
What trademark classes does G&J Marketing and Sales, LLC file in?
G&J Marketing and Sales, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are G&J Marketing and Sales, LLC's most well-known trademarks?
G&J Marketing and Sales, LLC's registered trademark portfolio includes well-known marks such as OMEGACLEAN and OMEGACLEAN PPE PERSONAL PROTECTION EXPERTS. These are among 2 currently registered trademarks in the portfolio.
What is G&J Marketing and Sales, LLC's trademark registration success rate?
G&J Marketing and Sales, LLC has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.